Study discovers novel molecular mechanism driving chemoresistance and tumor recurrence in gastric cancer

by The University of Hong KongProposed model for chemoresistance driven by ADAR1-upregulated SCD1 in gastric cancer. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-38581-

Updated on: February 03,2024 15

Study discovers novel molecular mechanism driving chemoresistance and tumor recurrence in gastric cancer

by The University of Hong KongProposed model for chemoresistance driven by ADAR1-upregulated SCD1 in gastric cancer. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-38581-

Updated on:February 03,2024 15

Neutralizing the side effects of epidermal growth factor inhibitor drugs

by Justin Jackson , Medical XpressIdentifying compounds that block anti-EGFR monoclonal antibodies binding to EGFR. (A) Illustration of the process used to identify lead compounds. "Hit" mol

Updated on: February 03,2024 19

Neutralizing the side effects of epidermal growth factor inhibitor drugs

by Justin Jackson , Medical XpressIdentifying compounds that block anti-EGFR monoclonal antibodies binding to EGFR. (A) Illustration of the process used to identify lead compounds. "Hit" mol

Updated on:February 03,2024 19

Researchers identify needs of rural-based physicians to optimize cancer survivorship care

by University of MissouriCredit: Unsplash/CC0 Public DomainThe vast majority of cancer survivors rely on primary care clinicians for follow-up treatments, especially in rural areas, according to

Updated on: February 03,2024 13

Researchers identify needs of rural-based physicians to optimize cancer survivorship care

by University of MissouriCredit: Unsplash/CC0 Public DomainThe vast majority of cancer survivors rely on primary care clinicians for follow-up treatments, especially in rural areas, according to

Updated on:February 03,2024 13

Research raises hopes for new treatment of fusion-driven cancer

by Aarhus UniversityFusion-gene disruption strategy.ADual intron-targeting CRISPR-Cas9-mediated disruption ofRUNX1-RUNX1T1. sgRNAs targeting intron 4 ofRUNX1(orange)

Updated on: February 03,2024 10

Research raises hopes for new treatment of fusion-driven cancer

by Aarhus UniversityFusion-gene disruption strategy.ADual intron-targeting CRISPR-Cas9-mediated disruption ofRUNX1-RUNX1T1. sgRNAs targeting intron 4 ofRUNX1(orange)

Updated on:February 03,2024 10

Study highlights promising drug combination for treating resistant breast cancer

by Lisa Marshall,University of Colorado at BoulderCredit:Cell(2023). DOI: 10.1016/j.cell.2023.05.013Cancer cells are even smarter than scientists previously believed, according to ne

Updated on: February 03,2024 15

Study highlights promising drug combination for treating resistant breast cancer

by Lisa Marshall,University of Colorado at BoulderCredit:Cell(2023). DOI: 10.1016/j.cell.2023.05.013Cancer cells are even smarter than scientists previously believed, according to ne

Updated on:February 03,2024 15

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on: February 03,2024 10

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on:February 03,2024 10

Study: AI outperforms standard risk model for predicting breast cancer

by Radiological Society of North AmericaRight medial lateral oblique (RMLO) screening mammograms show negative results from 2016 in (A) a 73-year-old woman with Mirai artificial intelligence (AI)

Updated on: February 03,2024 0

Study: AI outperforms standard risk model for predicting breast cancer

by Radiological Society of North AmericaRight medial lateral oblique (RMLO) screening mammograms show negative results from 2016 in (A) a 73-year-old woman with Mirai artificial intelligence (AI)

Updated on:February 03,2024 0

Examining the pesticides that may increase cancer risk in children

by Anna Novoselov,University of California, Los AngelesEstimated Odds Ratios and 95% Confidence Intervals from the Hierarchical Logistic Regression Model for all cases combined. Credit:Int

Updated on: February 03,2024 13

Examining the pesticides that may increase cancer risk in children

by Anna Novoselov,University of California, Los AngelesEstimated Odds Ratios and 95% Confidence Intervals from the Hierarchical Logistic Regression Model for all cases combined. Credit:Int

Updated on:February 03,2024 13

New research in finds telemedicine consistently outperforms in-person visits for cancer care when both are available

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research in the May 2023 issue of theJournal of the National Comprehensive Cancer Networkfrom Moffitt Cancer Ce

Updated on: February 03,2024 12

New research in finds telemedicine consistently outperforms in-person visits for cancer care when both are available

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research in the May 2023 issue of theJournal of the National Comprehensive Cancer Networkfrom Moffitt Cancer Ce

Updated on:February 03,2024 12

Researchers ID novel treatment pathway for deadly pancreatic cancers

by Johns Hopkins University School of MedicineThe High Mobility Group A1 (HMGA1) protein functions as a "molecular switch" that "flips on" expression and secretion of a critic

Updated on: February 03,2024 12

Researchers ID novel treatment pathway for deadly pancreatic cancers

by Johns Hopkins University School of MedicineThe High Mobility Group A1 (HMGA1) protein functions as a "molecular switch" that "flips on" expression and secretion of a critic

Updated on:February 03,2024 12

Team studies association between tumor mutations and meningioma recurrence in Grade I/II disease

by Impact JournalsAdjusted progression-free survival hazard ratios for genes examined. Credit: 2022 Dullea et al.A new research paper titled "Association between tumor mutations and meningioma re

Updated on: February 03,2024 20

Team studies association between tumor mutations and meningioma recurrence in Grade I/II disease

by Impact JournalsAdjusted progression-free survival hazard ratios for genes examined. Credit: 2022 Dullea et al.A new research paper titled "Association between tumor mutations and meningioma re

Updated on:February 03,2024 20

Researchers identify factors associated with COVID-19 vaccination acceptance among cancer patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainCancer patients are at higher risk of poor outcomes from COVID-19 infection due to their disease and ther

Updated on: February 03,2024 12

Researchers identify factors associated with COVID-19 vaccination acceptance among cancer patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainCancer patients are at higher risk of poor outcomes from COVID-19 infection due to their disease and ther

Updated on:February 03,2024 12